Sigachi Industries Limited has informed the Exchange about Investor Presentation
SIGACHI INDUSTRIES LIMITED
CIN: L24110TG1989PLC009497 AN EXCiPACT GMP, ISO 9001:2015 &FSSC 22000 CERTIFIED COMPANY
s
To,
Date: 06.12.2022
The Manager BSE Limited P. J. Towers, Dalal Street Mumbai-400001 (BSE Scrip Code: 543389)
Dear Sir/Madam,
The Manager, NSE Limited, Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai- 400051. (NSE Symbol: SIGACHI)
Sub: Investor Presentation November 2022
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015, and with reference to the subject cited, please find enclosed the Investor Presentation. The same is also uploaded on the website of the Company www.sigachi.com .
This is for your information and records.
Thanking You,
Yours faithfully For Sigachi Industries Limited
Shreya Mitra Company Secretary and Compliance Officer
Registered Office: #229/1 & 90, 2nd Floor, Kalyan’s Tulsiram Chambers, Madinaguda, Hyderabad-49, Telangana State, India.
Email: info@sigachi.com, Customer Service +91 40 40114874 - 76
SHREYA MITRADigitally signed by SHREYA MITRA Date: 2022.12.06 16:45:01 +05'30' Sigachi Industries Limited Investor Presentation November - 2022
Snapshot
Legacy of more than 3 decades in manufacturing of cellulose-based excipient
Supported by Experienced Management Team
Long standing Pan India presence & Exports to more than 40 countries
R&D Facility in Dahej is approved by DSIR and also have 2 other in- house laboratories
3 state-of-the-art manufacturing facilities situated in Hyderabad and Gujarat
3 year CAGR
Revenue: 25% EBITDA: 27% PAT: 28%
Sigachi Industries Limited
2
Company Overview
Company Overview
• Sigachi Industries Limited (Sigachi), incorporated in the year 1989, is one of the
leading manufacturers of Micro Crystalline Cellulose (MCC) in the world.
Revenue (INR Mn) & EBITDA Margins (%)
2,503
• Sigachi manufactures
excipients, which predominantly find usage in the pharmaceutical, supplement and food industries.
cellulose-based
high-quality
• The company has created a niche in manufacturing highly innovative pre- formulated excipients & 60+ widely used excipients of international quality standards.
• With two facilities in Gujarat and one in Telangana, Sigachi ensures supply chain
reliability for its customers in India and across the globe.
• Sigachi has a global sales and distribution network and exports to more than 40 countries across Asia, Australia, American Continent, Europe and Middle East.
• From its state-of-the-art R & D facility the company ensures continuous
innovation to efficiently meet evolving customer demands.
• The company also has an agreement with Gujarat Alkalies and Chemicals Limited (“GACL”) for operating and managing the manufacturing units owned by GACL and for contract manufacturing of sodium chlorate, stable bleaching powder and poly aluminum chloride.
1,928
1,608
20.12%
21.21%
20.27%
1,391
17.83%
FY20
FY21
FY22
H1-FY23
Sigachi Industries Limited
4
Board of Directors and Key Management Personnel
Mr. R P Sinha Founder, Chairperson, Whole-Time Director
Mr. Chidambarnathan Shanmuganathan Co-Founder, Whole-Time Director
• Holds Master’s degree in Chemical Hindu
from Banaras
Engineering University
• He has over 3 decades of experience in the cellulose and fine chemicals industry • Has played an instrumental role in setting up of the wholly owned Subsidiary, Sigachi US Inc. and in expansion of our export operations
PG
• Holds
business Diploma administration from Annamalai University • Has over 5 decades of experience in the chemicals & derivatives of
in
field of cellulose
• Has played an instrumental
role in expanding the domestic operation & in setting up of manufacturing units in Gujarat
Mr. Swami Das Nigam Chairman, Non-Executive Director
• Holds a Bachelor’s degree in Engineering from Birla Engineering College,
(Electrical) Pilani.
• Holds experience of more than 4 decades in Business Operations at Senior Management positions for diverse businesses.
• He has played an instrumental
role in management of Projects from Concept to Commissioning and also strong acumen in fields of Regulatory, Technical Audits, Energy Conservation and Cost Control.
Mr. Amit Raj Sinha MD & CEO
Mr. OS Reddy Chief Financial Officer
•
• He has an MBA from Indian School of Business, B. Tech & fellow member of the Institute of Engineers forces onboard Served in Indian naval warships & other vital defence installations. • Has over 15 years of experience in the pharma and fine chemicals & has played an instrumental role in strengthening the R&D Division.
• He is
a Chartered Accountant by profession and an MBA from Sikkim Manipal University
• Over 25 years of industry experience & over 15 years in pharmaceuticals and chemicals
• Overall,
in-charge
of
the
finance,
accounts and compliance functions
Sigachi Industries Limited
5
Key Milestones
Incorporated as ‘Sigachi Chloro- Chemicals Private Limited’ with the business to manufacture paraffin oil
Began in-house manufacturing of alpha cellulose
Started manufacturing of premium grade MCC by commissioning a spray drier and a multi-fuel furnace, which increased capacity from 720 to 1080 MTPA
Registered its Drug Master File (“DMF”) for the first time under the US FDA enabling to augment the export operations
Setting up of 100 % export-oriented unit (“EOU”) for manufacturing MCC in the SEZ at Dahej, Gujarat.
The R&D division innovated a novel filtration process for manufacturing MCC
Merger of Sigachi Cellulose Private Limited and Sigachi Plasticizers Private Limited with the company
Received ISO 9001:2015 for all manufacturing units
1989
1990
1996
1998
2000
2006
2007
2008
2009
2010
2011
2012
2014
2016
2020
2021
Diversified to manufacture microcrystalline (MCC) cellulose
Commenced its export operations by exporting its product, MCC to Bangkok
Set up a unit for manufacturing MCC at Jhagadia,
R&D laboratory received an accreditation from Department of Science and Industrial Research to undertake R&D
Commenced the commercial production of MCC at manufacturing unit situated at Jhagadia
Commenced the commercial production of MCC at the manufacturing unit situated at Dahej
Received ISO 9001:2008 certificate for the management system situated at Jhagadia
Got listed on NSE & BSE on Nov 15, 2021
Sigachi Industries Limited
6
Global Presence
Operating through non- exclusive distributors having strong market presence
Strong relationship with end customers and distributors
Trading business of MCC powder, food & pharma ingredients is operated through the subsidiary Sigachi US Inc
Manufacturing Facilities
Unit 2 - Jhagadia, Gujarat Unit 3 - Dahej, Gujarat Unit 1 – Hyderabad, Telangana
Operating through merchant exporters
More than 2 decades of operation through exclusive distributor in ANZ market
Geographical Revenue Mix % (FY22)
2% 2%
2%
2%
2% 3%
5%
12%
9%
15%
26%
20%
India
USA
Australia
Sweden
Denmark
Egypt
China
Spain
UK
Poland
Sales Mix
38.82%
31.85%
24.57%
24.51%
61.18%
68.15%
75.43%
75.49%
FY20
FY21
FY22
H1-FY23
Export
Domestic
Sigachi Industries Limited
7
Manufacturing Plants
• Sigachi has three manufacturing units namely, Hyderabad, Telangana (“Unit I”), Jhagadia,
Gujarat (“Unit II”) and Dahej, Gujarat (“Unit III”).
90.91%
Manufacturing Capacities (MTPA) & Capacity Utilisation in % (as on H1 FY23)
98.34%
95.42%
• These units help in providing timely, efficient and customized delivery of the products to
domestic and international customers.
• Unit II and Unit III are spread over an area of approximately 1.44 acres and 2.67 acres,
respectively.
• The manufacturing plant at Unit III is located in the SEZ and is entirely an export-oriented unit.
• Sigachi intends to tap the growing demand of MCC by expanding the manufacturing capacities
at Unit II and Unit III.
2,400
2,182
1,450
1,426
3,300
3,149
Dahej
Jhagadia
Hyderabad
Installed Capacity
Production Volume
Hyderabad Plant
Jhagadia Plant
Dahej SEZ Plant
Sigachi Industries Limited
8
R&D and Quality Assurance
R&D: • The Research and Development division is located in Jhagadia and Dahej with the objective to
implement a performance-oriented approach with the help of technologies developed in-house.
• R&D Division is equipped with the necessary facilities to carry out all necessary trials to develop new
molecules from concept to commissioning.
• R&D Division works on specific projects along with experts in their respective fields, focusing on
application research to explore new grades of MCC.
• Laboratory at Jhagadia has been approved and has received an accreditation from Department of
Science and Industrial Research (“DSIR”).
Quality Assurance: • The company has quality control and assurance division in all manufacturing units and carries out all the required tests on the materials received including raw material which are used in the manufacturing process and also on the final products.
• Team of experts carries out various application tests to ascertain the true nature of the constituents and ensure the quality of our products as per the customer requirements and international standards.
• Company has received various certifications for the manufacturing process, managements systems
implemented and the raw materials used during the manufacture of the products.
Sigachi Industries Limited
9
Marquee Clients
Sigachi Industries Limited
10
Awards and Accolades
‘Achiever of Silver Star’ in the category of Medium Scale Industries in the HR Best Practices 2019 program’
Honored with ‘DHL SME ZEE Business Award’
Awarded the title of ‘India’s Small Giants Emerging Enterprises of India – Roll of Honor for 2014’ by Life Insurance Corporation of India
Awarded the title of ‘SME Achievers of 2013’ by Bank of India
Awarded with the ‘National Award for Outstanding Entrepreneurship’ by the Government of India
Sigachi Industries Limited
11
Business Overview
About Microcrystalline Cellulose (MCC)
• Microcrystalline Cellulose is refined wood pulp and it is a chemically inert substance, extensively used in food,
pharmaceuticals, cosmetic, and polymer composite industries.
• MCC is considered as a diluent having self-binding properties and it is one of the preferred direct compressible
binder owing to its dry binding properties.
• It has distinguished chemical and physical properties from other excipients and due to its chemically inert
nature MCC is compatible with most Active Pharmaceutical Ingredients (APIs).
• Good absorption capacities, broad particle size profile and good compressibility with fast disintegration has
placed the MCC as the most widely used excipient in the pharmaceutical industry.
• MCC is used for the production of solid dosage form due to its good compressibility, compatibility and loading capacity of drugs. In the food industry, it is widely used as a stabilizer, anti-caking agent, fat substitute and emulsifier in food production.
• It has use in cosmetics as an abrasive, absorbent, aqueous viscosity increasing agent, binder, bulking agent, emulsion stabilizer, slip modifier, and texturizer, which can be found in various hair and skin care products as well as makeup.
• MCC is prepared by hydrolysis process at temperature, neutralized after completion of hydrolysis and then
filtered and dried by spray drying or bulk drying.
MCC Market Share Based on End - Use
Industry Pharmaceuticals Food & Beverage Cosmetics & Personal Care Others
Approx % 35-40 20-25 15-20 10-15
Source: Industry and CARE Advisory
Sigachi Industries Limited
13
MCC Manufacturing Process
Hydrolysis of the wood pulp sheets
Filtration
Drying
Packaging
1. Sheets of wood pulp are added to glass lined reactors, for hydrolysis of the wood pulp which is carried out at the required temperature and pressure. The slurry
then formed goes to the Quality Division that tests the nature and texture of the slurry.
2. The slurry is then sent for filtration. At filter press, the slurry is passed through in to separate ‘mother liquor’ from the slurry and the ‘filtrate’ is sent to the effluent treatment plant. The residual cake is washed during the process to make it neutral as well as salt free. Air is passed through the cake to reduce the moisture content.
3. Due to the varied applications of the products in different sectors, different drying techniques are used on the wet cakes. The various drying techniques
adopted during the manufacturing process have been detailed below:
a) Fluidized bed drying process (“FBD”): Basically a hot air drying process where the residual moisture is reduced to a desired level and to achieve a finer micron size it is further subjected to the pulverization process. b) Spin Flash Dryer (“SFD”): The wet cake is subjected to hot air which is passed through the spin agitator, agitation speed is decided as per the particle size which has to be achieved. The powder is discharged from the cyclone through a rotary air lock valve. c) Spray Drying: The slurry is sprayed in the spray dryer where drying takes place using hot air. The product obtained from (a) and (b) are blended and sieved to make a uniform, homogeneous and a standard batch size for final packing. However, the product obtained from spray drying process is sieved and directly sent for packaging.
4.
The final product is packed in as specified by the customers. Once the packaging is done, the final products are then transferred to quarantine room for testing then transferred to finished goods storage area.
Sigachi Industries Limited
14
Wood Pulp - Key Raw Material
• The major raw material used in the manufacture of MCC is purified dissolving wood
pulp bales.
• These are imported from Canada, South Africa, Thailand, Indonesia and America
from various suppliers.
• The chemical and physical properties of the pulp determine the final quality of the
finished products.
• The wood pulp bales are imported based on the quality and the price at which they
are available with the suppliers.
• Quality Division carries out various tests such as ash content, water soluble substances, ether soluble substances, moisture content, paper brightness test, black particles etc.
• Domestically sourced Hydrochloric acid and other auxiliary chemicals are also used
for converting wood pulp into MCC.
Sigachi Industries Limited
15
Sigachi in Microcrystalline Cellulose (MCC)
• Sigachi is the largest manufacturers of MCC in India and one of the leading manufacturers globally, with
over three decades of experience.
• It manufactures MCC of 60 different grades ranging from 15 microns to 250 microns having varied
applications in the pharmaceutical, food, nutraceutical and cosmetic industry.
• Sigachi sells its cellulose based products under the following brands:
o HiCelTM o AceCelR o CoatCelR o GloCelR o BARETabR
MCC Revenue Trend (INR Mn)
2,265
1,806
1,287
1,500
• These products are distinguished with the help of different drying techniques during the manufacturing
FY20
FY21
FY22
H1-FY23
process.
• The company produces various grades of the product in combination with various chemicals like colloidal silicon dioxide, carboxy cellulose sodium, mannitol etc. to cater to the growing market of the co-processed excipients.
Revenue Breakup (FY22)
5% COSMETICS
20% FOOD & NUTRA
75% PHARMA
Sigachi Industries Limited
16
Pharma Application Segments
Pharma Portfolio consists of: • Antiulcerative API’s & their
Thickeners/Stabilizers
intermediates • Pre-Formulated Excipients • High Functionality Excipients • • Binders • • • •
Superdisintegrants Lubricants Functional Fillers/Carriers Spheres
Spheres
Tablets
Powder blends
Suspensions
Health Supplements
Hard Capsule Filling
Sigachi Industries Limited
17
Food Application Segments
Stabilizer & Emulsifier
Our Food Ingredients are Primarily Used as: • • Dietary Fibre • Bulking Agent • Texturizer • Anticaking Agent • Flow Improver
Bakery
Dairy
Confectionery
Instant Food
Salad & Soups
Beverages
Sigachi Industries Limited
18
Cosmetics and Chemical Application Segments
COSMETIC APPLICATIONS
Mascara/Eyeliner
Toothpaste
Talcum Powder
Creams & Lotions
Shower Gels
Facial Scrubs
CHEMICAL APPLICATIONS
Sensory Agent Texturizer Filler
Cosmetic Ingredients are primarily used as: • • • • Humectant • Flow Enhancer • Anti-Caking Agents
• In the chemical sector the cellulose products are used in electrodes, and as
filter aid. These products are economic and environmentally friendly.
• MCC prevents cracks in welding rods, gives a good texture and produce less
slag and is therefore suitable for deep penetrating welding.
Sigachi Industries Limited
19
Strategic Overview
Key Strengths
One of the leading manufacturers of MCC in India with over 30 years’ experience: • Made advancements in development of MCC and positioned as one of the key manufacturing players globally
• Technical Division infrastructure, advantage in India
capabilities, and
gives
capable R&D manufacturing first mover
a
India
Pan presence: • A long-standing market presence in
International market
and
India and internationally
• Export
to
products
countries including Australia, USA, South America, U.K., Poland, Italy, Denmark, China, Colombia, Bangladesh, to name a few
41
standing
Presence across diverse industry verticals with relationship with long customers : • Customization of products based on and
specifications
customer requirements
• Track record of consistent delivery of quality and cost-effective products and solutions through strategic alignment of key customers’ goals over the years
Growth led by continuous investment and focus on R&D: • Regular investments in R&D to expand the product offerings and to streamline manufacturing process
• The laboratory in Dahej is approved by
• 2 in-house laboratories in Hyderabad
DSIR
and Jhagadia.
Comprehensive product portfolio enables to serve diverse end-use applications: • Customize the usage and application of industries to food, nutraceuticals
to various not
the products including but pharmaceutical, and cosmetics
limited
• Manufacture MCC in various grades ranging from 15 microns to 250 microns
Strategically located manufacturing facilities • Set up 3 multi locational manufacturing units namely, Hyderabad, Telangana (“Unit I”), Jhagadia, Gujarat (“Unit II”) and Dahej, Gujarat (“Unit III”) which helps provide timely, efficient and customized delivery of the products in terms with the specific demographic needs
Sigachi Industries Limited
21
Strategy going forward
Diversifying Product Mix: Manufacturing higher grades of products as well as enhancing product basket by offering innovative new value-added products
Enhancing global footprint: Increasing market share by exploring untapped markets
Expanding manufacturing capacites: At Dahej and Jhagadia to focus on the growing demand of MCC, setting up a new unit at Kurnool to manufacture CCS
Increasing focus on core business segment: Pushing efforts towards manufacturing MCC and its various grades for various industries or applications leading to optimum resource utilization
Widen its horizon: Company will venture into the human nutritional segment, with a prime focus on B2B markets, in India and across the globe. The product portfolio will include spray- dried ingredients, micronutrient premixes and other allied products.
Launch of Health Care Division : Capture the growing OTC market and cater to the increasing health expenditure in India due to the pandemic with focus to increase brand extension through launch of various products in the healthcare sector
Ensuring that the customer base increases through marketing efforts: Enhancing customer base through marketing efforts and customizing products for various applications as per requirements of customers
Sigachi Industries Limited
22
Capex
• The company is expanding the production capacity of MCC by increasing the
manufacturing capacity of units in Dahej and Jhagadia.
• Setting up of the proposed unit for manufacturing higher grades of MCC and CCS will
result in increased revenues and profitability.
• The strategic decision to expand manufacturing units will increase the ability to cater
to the increasing demand of its products.
• The company expects to benefit from the economies of scale brought about by such
increased production capacity.
Manufacturing capacities at existing facilities (units in MTPA)
Unit Location
Existing Capacity (MCC)
Proposed Expansion (MCC)
Expected Capacity (MCC)
Dahej
4,800
3,600
8,400
Jhagadia
Hyderabad
2,600
3,600
6,200
6,400
--
6,400
Capital Expenditure (INR Mn)
465
209
87
100
123
FY21
H1-FY22
FY22
FY23E
FY24E
Sigachi Industries Limited
23
Croscarmellose Sodium: New Product Launch
• The company plans to foray into the production of Croscarmellose Sodium (CCS).
• Sigachi plans to invest INR 32 Cr for the proposed unit at Kurnool which will have an expected installed capacity of 4 MTPA of CCS. This project is expected to be completed by FY24.
• CCS is a modified sodium carboxymethyl cellulose used as a disintegrant in pharmaceutical
formulations and provides long term stability.
• It is an insoluble and hydrophilic polymer which aids in the dissolution of the dietary supplements and pharmaceutical tablets, granules, and capsules. CCS is used in various industries such as pharmaceutical, food, nutraceutical, textile, etc.
• The mechanism of action of croscarmellose sodium in a tablet starts when it swells, which
is highly dependent on the penetration of a liquid into the tablet.
• The swelling breaks the tablet's binding forces, causing it to disintegrate and thereby
accelerating the dissolution of the active pharmaceutical ingredient (API).
• Its level of use ranges from 0.5 to 5 percent, but 0.5 to 2 percent is sufficient in most
formulations.
• CCS is used with binders as greater the amount of binder in the tablet, the stronger it
becomes.
Sigachi Industries Limited
24
CSR Initiatives
Educating The Less Privileged
Welfare
Development Program
• The Zilla Parishad High- Sigachi continues to pay part salary of attenders and other staff, and also supports students by procuring study materials.
• Celebrated “Daan Utsav – Joy of Giving Week’ an employee led volunteering activity to support underprivileged children and senior citizens.
• Cheers Children Home- Supporting students
with their school and college fees.
• Birsa Mundra High School,
Jharkhand – Helped equip the school with benches and desks for students. We also supported to provide for pure drinking water facility and toilets.
• Environment Day was celebrated in full spirit across the units where Sigachians pledged to work towards a better and greener planet by contributing in every little way that they can.
• Tree plantation drive was organized on the occasion of World Environment Day at our situated in Dahej.
•
•
Gujarat
District,
The flagship CSR initiative “Integrated in Bharuch & Development Program” at aims Narmada improving nutrition, drinking water & hygiene conditions, sanitation, and access to renewable energy to 1000+ tribal households. Also focus on improving Education & Skilling, Healthcare, Nutrition, Women Empowerment, Water Management, Sustainable Sourcing, Waste Management and Community Development.
Sigachi Industries Limited
25
Industry Overview
MCC Industry
• Microcrystalline Cellulose Market size is forecast to reach USD 1.4 Bn by CY 2025, growing at a CAGR of
7.25% during CY 20-25.
• Increasing application of MCC in various industries is a major factor propelling growth of the global MCC market. For instance, MCC is used as stabilizer and anti-caking agent in beverages. It is also used as a cold and hot stabilizer, in frozen food, in order to improve the shelf life of the product.
• MCC is widely used in pharmaceuticals, owing to its tasteless, odor less, and chemical inertness properties. • Among end-use industries, pharmaceutical segment accounted for a dominant share in the market, owing
to high use of microcrystalline cellulose in pharmaceutical.
• Furthermore, food and beverage segment is expected to exhibit a substantial growth in the global microcrystalline cellulose market over the forecast period. This is due to wide application of MCC in various food and beverages including desserts, frozen food, dairy products, and baked goods. it is also used as a fat replacer and helps maintain the food consistency.
• In line with the global trend, pharmaceutical will be major growth segment followed by food & beverages
and cosmetic for MCC Market in India.
MCC Market - Region Wise (in USD Mn)
158 218
287
323
167
230
303
338
176
242
319
353
186
256
337
369
210
289
382
224
308
406
434
462
CY20
CY21 (E) CY22 (P) CY23 (P) CY24 (P) CY25 (P)
Europe North America
Asia Pacific
Rest of World
MCC Market in India (USD Mn)
43
47
21
13
26
13
6
3
6
3
30
15
34
18
8
3
10
3
22
14
25
18
4
4
CY20
CY21 (E)
CY22 (P)
CY23 (P)
CY24 (P)
CY25 (P)
Source: CARE Report – August 2021
Pharmaceuticals
Food & Beverage
Cosmetics & Personal Care
Others
Sigachi Industries Limited
27
Key Growth Drivers
Pharmaceutical Industry: • The growth is mainly due to the companies rearranging their operations and recovering from the
Indian Pharma Market (USD Bn)
130
COVID-19 impact.
• Medicine spending in India is projected to grow 9 -12% over the next five years, leading India to
65
become one of the top 10 countries in terms of medicine spending.
41
• Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti- diabetes, anti-depressants and anti-cancers, which are on the rise.
Food & Beverage Industry: •
Innovative advertisements, rise in supermarkets and e-commerce boom, creating increasing awareness among consumers and also making the products easily accessible to the consumers. Increase in consumption of fast growing F&B (Food and Beverage) segments during special occasions and celebrations. Increase in tourism in India and international travel by Indians increased the interest of Indians in international food products.
•
•
Cosmetic Industry: • With the improving purchasing power, demand for enhanced products and increasing image consciousness of the Indian clientele, many international brands are establishing footprints in India which will be a key factor aiding this growth.
• Herbal cosmetics products are driving growth due to increasing adoption, and the segment alone is
expected to grow at 15%.
• Social media & favorable demographics are playing an important role in spreading awareness about cosmetics products and developing fashion consciousness, not only in metros but also in tier-1 & 2 cities.
Source: CARE Report – August 2021
CY21
CY24 (P)
CY30 (P)
Food & Beverage Market in India (USD Bn)
516
399
142
184
308
238
CY20
CY21 (E) CY22 (P) CY23 (P) CY24 (P) CY25 (P)
Cosmetics Market Size (USD Bn)
31
10
CY20
13
CY25 (P) CY21 (E) Sigachi Industries Limited
28
Financial Overview
Historical Consolidated Financial Performance
Particulars (INR Mn)
Operational Revenue
Total Expenses
EBITDA
EBITDA Margin (%)
Depreciation and amortisation
Finance costs
Other Income
PBT
Tax Expense
PAT
PAT Margin (%)
Diluted EPS
FY20
1,391
1,143
248
FY21
1,928
1,540
388
FY22
2,503
1,972
531
H1-FY23
1,608
1,282
326
17.83%
20.12%
21.21%
20.27%
20
23
48
253
50
203
23
13
33
385
82
303
29
12
26
516
116
400
29
17
38
318
54
264
14.59%
8.81
15.72%
13.13
15.98%
15.44
16.42%
8.59
Sigachi Industries Limited
30
Historical Consolidated Balance Sheet
Particulars (INR Mn)
FY20
FY21
H1-FY23
Particulars (INR Mn)
FY20
FY21
EQUITY
Equity Share Capital
Other Equity
NON-CURRENT LIABILITIES
a) Financial Liabilities
i) Borrowings
ii) Lease Liability
b) Provisions
c) Deferred tax liabilities (net)
CURRENT LIABILITIES
a) Financial Liabilities
i) Borrowings
ii) Lease Liabilities
iii) Trade Payables
iv) Other financial liabilities
b) Other current liabilities
c) Provisions
TOTAL LIABILITIES
TOTAL EQUITY AND LIABILITIES
646
77
569
55
19
-
7
29
390
942
77
865
70
19
-
8
43
322
270
183
-
72
14
33
1
-
80
7
43
9
FY22
2,277
307
1,970
76
12
-
9
55
515
332
-
106
6
59
12
2,504
307
2,197
295
10
231
8
46
727
384
36
215
5
69
18
NON-CURRENT ASSETS
a) Property, plant and equipment
b) Capital work-in-progress
c) Right of Use Assets
c) Intangible assets
d) Financial assets
i) Investments
ii) Other Financial Assets
e) Other non-current assets
CURRENT ASSETS
a) Financial Assets
i) Trade Receivables
ii) Cash and cash equivalents
iii) Bank balances other than above
iv) Other financial assets
b) Other current assets
445
1,091
392
1,334
591
2,868
1,022
3,525
c) Inventories
TOTAL ASSETS
371
312
31
-
4
-
14
10
720
276
88
18
46
13
279
463
376
37
-
3
2
18
27
871
358
159
21
100
21
212
FY22
1,069
527
97
-
7
2
351
85
H1-FY23
1,882
794
177
260
7
2
479
164
1,799
1,643
601
291
403
128
71
305
791
63
177
156
93
363
1,091
1,334
2,868
3,525
Sigachi Industries Limited
31
Consolidated Financial Highlights
Operational Revenue (INR Mn)
EBIDTA (INR Mn) & EBITDA Margins (%)
PAT (INR Mn) & PAT Margins (%)
1,928
1,391
2,503
1,608
531
388
248
17.83%
20.12%
21.21%
400
303
326
20.27%
203
264
16.42%
14.59%
15.72%
15.98%
FY20
FY21
FY22
H1-FY23
FY20
FY21
FY22
H1-FY23
FY20
FY21
FY22
H1-FY23
Net Debt to Equity (x)
Cash Conversion Cycle (Days)
0.28
0.22
130
117
92
0.06
ROCE (%) and ROE(%)
ROE
ROCE
40%
31%
39%
32%
22%
18%
FY20
FY21
FY22
H1-FY23
FY20
FY21
FY22
FY20
FY21
FY22
-0.15
Sigachi Industries Limited
32
Share Price Movement Upto 30th Sept, 2022
Capital Market Information
20%
10%
0%
-10%
-20%
-30%
-40%
-50%
-60%
-70%
Nov-21
Dec-21
Jan-22
Feb-22
Mar-22
Apr-22
May-22
Jun-22
Jul-22
Aug-22
Sep-22
SENSEX
SIGACHI
Market Data (INR) as on 30th Sept, 2022
Shareholding Pattern as on 30th Sept, 2022
Face Value
CMP
52 Week H/L
Market Cap (INR Mn)
Shares O/S (Mn)
Avg. Vol. Since Listing (‘000)
10.0
268.6
648.0/231.3
8,258.9
30.7
270.31
Public 52%
Promoters 48%
33
Sigachi Industries Limited
33
Disclaimer
Sigachi Industries Limited Disclaimer: No representation or warranty, express or implied, is made as to, and no reliance should be placed on the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. Certain statements made in this presentation may not be based on historical information or facts and may be "forward looking statements" based on the currently held beliefs and assumptions of the management of Sigachi Industries Limited (Sigachi), which are expressed in good faith and in their opinion reasonable, including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects and future developments in its industry and its competitive and regulatory environment
Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company or industry results to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements, including future changes or developments in the Company’s business, its competitive environment and political, economic, legal and social conditions. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties and other factors, viewers of this presentation are cautioned not to place undue reliance on these forward-looking statements. The Company disclaims any obligation to update these forward- looking statements to reflect future events or developments
This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. This presentation does not constitute an offer or invitation to purchase or subscribe for any securities in any jurisdiction, including the United States. No part of it should form the basis of or be relied upon in connection with any investment decision or any contract or commitment to purchase or subscribe for any securities. None of our securities may be offered or sold in the United States, without registration under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption from registration there from
This presentation is confidential and may not be copied or disseminated, in whole or in part, and in any manner
Valorem Advisors Disclaimer: Valorem Advisors is an Independent Investor Relations Management Service company. This Presentation has been prepared by Valorem Advisors based on information and data which the Company considers reliable, but Valorem Advisors and the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Valorem Advisors also hereby certifies that the directors or employees of Valorem Advisors do not own any stock in personal or company capacity of the Company under review
For further details, please feel free to contact our Investor Relations Representatives:
Mr. Anuj Sonpal Valorem Advisors Tel: +91-22-4903-9500 Email: sigachi@valoremadvisors.com
Sigachi Industries Limited
34
Thank You